Operating Lease, Right-of-Use Asset of IGC Pharma, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
IGC Pharma, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • IGC Pharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $13,000, a 92% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

IGC Pharma, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $13,000 -$148,000 -92% 30 Sep 2025 10-Q 14 Nov 2025 2026 Q2
Q2 2025 $16,000 -$177,000 -92% 30 Jun 2025 10-Q 14 Aug 2025 2026 Q1
Q1 2025 $98,000 -$100,000 -51% 31 Mar 2025 10-Q 14 Nov 2025 2026 Q2
Q4 2024 $129,000 -$98,000 -43% 31 Dec 2024 10-Q 14 Feb 2025 2025 Q3
Q3 2024 $161,000 -$102,000 -39% 30 Sep 2024 10-Q 12 Nov 2024 2025 Q2
Q2 2024 $193,000 -$102,000 -35% 30 Jun 2024 10-Q 07 Aug 2024 2025 Q1
Q1 2024 $198,000 -$128,000 -39% 31 Mar 2024 10-K 27 Jun 2025 2025 FY
Q4 2023 $227,000 -$130,000 -36% 31 Dec 2023 10-Q 14 Feb 2024 2024 Q3
Q3 2023 $263,000 -$124,000 -32% 30 Sep 2023 10-Q 09 Nov 2023 2024 Q2
Q2 2023 $295,000 -$124,000 -30% 30 Jun 2023 10-Q 10 Aug 2023 2024 Q1
Q1 2023 $326,000 -$124,000 -28% 31 Mar 2023 10-K 24 Jun 2024 2024 FY
Q4 2022 $357,000 -$125,000 -26% 31 Dec 2022 10-Q 14 Feb 2023 2023 Q3
Q3 2022 $387,000 -$123,000 -24% 30 Sep 2022 10-Q 01 Nov 2022 2023 Q2
Q2 2022 $419,000 -$119,000 -22% 30 Jun 2022 10-Q 05 Aug 2022 2023 Q1
Q1 2022 $450,000 -$38,000 -7.8% 31 Mar 2022 10-K 07 Jul 2023 2023 FY
Q4 2021 $482,000 -$28,000 -5.5% 31 Dec 2021 10-Q 10 Feb 2022 2022 Q3
Q3 2021 $510,000 -$22,000 -4.1% 30 Sep 2021 10-Q 29 Oct 2021 2022 Q2
Q2 2021 $538,000 -$15,000 -2.7% 30 Jun 2021 10-Q 11 Aug 2021 2022 Q1
Q1 2021 $488,000 -$86,000 -15% 31 Mar 2021 10-K 23 Jun 2022 2022 FY
Q4 2020 $510,000 31 Dec 2020 10-Q 16 Feb 2021 2021 Q3
Q3 2020 $532,000 30 Sep 2020 10-Q 20 Nov 2020 2021 Q2
Q2 2020 $553,000 30 Jun 2020 10-Q 19 Aug 2020 2021 Q1
Q1 2020 $574,000 +$574,000 31 Mar 2020 10-K 14 Jun 2021 2021 FY
Q1 2019 $0 31 Mar 2019 10-K 13 Jul 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.